CN108378357A - 一种消除晚期肿瘤疼痛的食疗粉及其制备方法 - Google Patents
一种消除晚期肿瘤疼痛的食疗粉及其制备方法 Download PDFInfo
- Publication number
- CN108378357A CN108378357A CN201810164437.7A CN201810164437A CN108378357A CN 108378357 A CN108378357 A CN 108378357A CN 201810164437 A CN201810164437 A CN 201810164437A CN 108378357 A CN108378357 A CN 108378357A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- dietotherapy
- tumor pain
- late tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 106
- 206010045171 Tumour pain Diseases 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 12
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 12
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 12
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 12
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 12
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 12
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 12
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 12
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 12
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 12
- 241000209140 Triticum Species 0.000 claims abstract description 12
- 235000021307 Triticum Nutrition 0.000 claims abstract description 12
- 235000007215 black sesame Nutrition 0.000 claims abstract description 12
- 235000013312 flour Nutrition 0.000 claims abstract description 11
- 235000012054 meals Nutrition 0.000 claims abstract description 11
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 10
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 10
- 241000169546 Lycium ruthenicum Species 0.000 claims abstract description 10
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 10
- 230000008030 elimination Effects 0.000 claims abstract description 10
- 238000003379 elimination reaction Methods 0.000 claims abstract description 10
- 239000008103 glucose Substances 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims abstract description 7
- 241001092040 Crataegus Species 0.000 claims description 11
- 241000229143 Hippophae Species 0.000 claims description 9
- 206010027336 Menstruation delayed Diseases 0.000 claims description 5
- 235000013339 cereals Nutrition 0.000 claims description 5
- 230000002040 relaxant effect Effects 0.000 claims description 4
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 15
- 238000002560 therapeutic procedure Methods 0.000 abstract description 6
- 235000005911 diet Nutrition 0.000 abstract description 4
- 230000037213 diet Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 108700025716 Tumor Suppressor Genes Proteins 0.000 abstract description 3
- 102000044209 Tumor Suppressor Genes Human genes 0.000 abstract description 3
- 230000004614 tumor growth Effects 0.000 abstract description 3
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 240000000950 Hippophae rhamnoides Species 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000011282 treatment Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 208000008798 osteoma Diseases 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- WCNLCIJMFAJCPX-UHFFFAOYSA-N pethidine hydrochloride Chemical group Cl.C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 WCNLCIJMFAJCPX-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种消除晚期肿瘤疼痛的食疗粉,包括如下重量份的组分:小麦全粉15~25份、燕麦粉5~10份、海带粉1~5份、山楂粉3~5份、沙棘粉1~3份、黑枸杞粉1~2份、大豆粉3~5份、葡萄糖粉55~70份、黑芝麻粉4~6份、食盐0.2~0.5份。本发明属于中医药食疗技术领域,通过选择合适的纯天然食材及其配比,制备出一种安全无害,能有效抑制肿瘤生长,快速激活抑癌基因,迅速消除晚期肿瘤疼痛,避免对患者造成伤害和痛苦的消除晚期肿瘤疼痛的食疗粉。
Description
技术领域
本发明属于中医药食疗技术领域,具体是指一种消除晚期肿瘤疼痛的食疗粉及其制备方法。
背景技术
由于生活水平提高,工作压力加大,生态环境的变化,人们的健康状况也随着变化。尤其是肿瘤方面的疾病常有发生,肿瘤是一种严重损害人们身体健康,危及生命的疾病。目前,癌症治疗方法有手术治疗、放疗、化疗等。更有甚者患肿瘤癌症、乳腺炎、骨瘤、脉管炎、卵巢癌、膀胱癌等疑难病症缺少有效的治疗方法。这些疾病的发生,尤其是顽固的慢性病,慢养是治本除根唯一的出路。而大多数人急于治愈,选用见效最快的方法,往往欲速而不达,反而破坏了身体的免疫力,进一步加重了病情。所以,一定要慢病慢养,依靠人体自愈能力的自然而神奇的力量不断排毒更新,修复细胞与器官。
肿瘤病人,在晚期会伴随着疼痛,给病人带来疼痛的折磨。目前使用的镇痛药,如可待因、***,***、哌替啶、芬太尼等,虽然具有止痛作用,但其副作用较强,会产生较强的依赖性,不易长期服用。所以在给药条件和剂量上受到严格的控制,更谈不到长期用药的可能。使用中药治疗疼痛的比例越来越大,但以内服中药或中成药为多,临床疗效不甚理想,复发率高。寻找一种能够长期保持疗效且不反弹的止痛治疗方法和药物,已成为患者的迫切需求和医师的重点目标。
众所周知,是药三分毒,不能长期不间断地服药,药物的毒副作用是慢性病不能彻底康复的罪魁祸首。对抗药害有两种办法,第一,中医的全面调理、整体治疗的思想就是为了防止顾此失彼,而是中医平衡处理了药与病的关系。第二,是食疗法。现有技术中无论是西医治疗还是中药治疗,都有不足之处。选用无毒的食材,采用食疗方法治疗,运用中药巧妙搭配食物配方,完美地结合了两种办法,安全而高效,可起到很好的效果。
发明内容
为解决上述现有难题,本发明通过选择合适的纯天然食材及其配比,制备出一种安全无害,能有效抑制肿瘤生长,快速激活抑癌基因,迅速消除晚期肿瘤疼痛,避免对患者造成伤害和痛苦的消除晚期肿瘤疼痛的食疗粉。
本发明采用的技术方案如下:一种消除晚期肿瘤疼痛的食疗粉,包括如下重量份的组分:小麦全粉15~25份、燕麦粉5~10份、海带粉1~5份、山楂粉3~5份、沙棘粉1~3份、黑枸杞粉1~2份、大豆粉3~5份、葡萄糖粉55~70份、黑芝麻粉4~6份、食盐0.2~0.5份。
进一步地,一种消除晚期肿瘤疼痛的食疗粉,包括如下重量份的组分:小麦全粉16~24份、燕麦粉6~9份、海带粉2~4份、山楂粉4~5份、沙棘粉1.5~2.5份、黑枸杞粉1.2~1.8份、大豆粉4~5份、葡萄糖粉58~68份、黑芝麻粉4.5~5.5份、食盐0.25~0.35份。
进一步地,一种消除晚期肿瘤疼痛的食疗粉,包括如下重量份的组分:小麦全粉20份、燕麦粉8份、海带粉3份、山楂粉4.5份、沙棘粉2份、黑枸杞粉1.5份、大豆粉4份、葡萄糖粉60份、黑芝麻粉5份、食盐3份。
进一步地,一种消除晚期肿瘤疼痛的食疗粉,所述小麦全粉、燕麦粉、大豆粉、黑芝麻粉预先炒制后使用,所述山楂粉去核炒制后使用。
本发明还公开了一种消除晚期肿瘤疼痛的食疗粉的制备方法,包括如下步骤:
1)按照组分的重量份比称取各组分;
2)将上述各组分按比例混合、粉粹、研磨成食疗粉末,食疗粉末的粒径为100~150目,即可得本发明消除晚期肿瘤疼痛的食疗粉。
采用上述方案本发明取得有益效果如下:本发明消除晚期肿瘤疼痛的食疗粉精选合适的纯天然食材及其配比,各组分之间相互配合,协同作用,安全无害,能有效抑制肿瘤生长,快速激活抑癌基因,迅速消除晚期肿瘤疼痛,避免对患者造成伤害和痛苦的消除晚期肿瘤疼痛。本品减轻了肿瘤患者全身乏力、消瘦、病灶部位疼痛等症状,服用该消除晚期肿瘤疼痛的食疗粉在改善患者肿瘤症状的同时,还提高了患者的体力和精神状况。本品可抑制肿瘤的生长,避免病情的恶化,由于肿瘤细胞在体内生长很难察觉,当通过仪器可以观察到病灶时,往往病情已属于中晚期,而本发明消除晚期肿瘤疼痛的食疗粉在患者的服用过程中,对于不同的病程均有一定的治疗效果,对癌细胞的扩散起到良好的抑制作用。本品避免了患者的不良反应,降低对患者的伤害。该消除晚期肿瘤疼痛的食疗粉的食用,不像化疗那样对患者会造成各种不良感受,不仅对肿瘤细胞进行消灭,同时还会对机体正常细胞,尤其是增生活跃的细胞产生强有力的杀伤作用,这会使患者的身体出现不适症状,甚至不良反应严重到超出患者承受能力,还会造成化疗治疗进程的中断,进一步影响了病情的控制,另一方面,像脱发等症状还对患者的精神造成极大地伤害,使患者出现自卑、压抑等情绪,不利于病情的发展;而本发明消除晚期肿瘤疼痛的食疗粉的食用不会造成以上诸多伤害,能够在治疗疾病的同时,迅速消除晚期肿瘤疼痛,避免对患者造成伤害和痛苦的消除晚期肿瘤疼痛,使患者保持愉悦的心情,同时还对提高患者自身体质积极的作用。本发明提供的消除晚期肿瘤疼痛的食疗粉携带和食用方便,对人体作用时间持久,经临床试验验证,效果显著。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。
实施例1,本发明消除晚期肿瘤疼痛的食疗粉,包括如下重量份的组分:小麦全粉20份、燕麦粉8份、海带粉3份、山楂粉4.5份、沙棘粉2份、黑枸杞粉1.5份、大豆粉4份、葡萄糖粉60份、黑芝麻粉5份、食盐0.3份。
本发明消除晚期肿瘤疼痛的食疗粉的制备方法,包括如下步骤:
1)按照组分的重量份比称取各组分;
2)将上述各组分按比例混合、粉粹、研磨成食疗粉末,食疗粉末的粒径为120目,即可得本发明消除晚期肿瘤疼痛的食疗粉。
实施例2,本发明消除晚期肿瘤疼痛的食疗粉,包括如下重量份的组分:小麦全粉18份、燕麦粉6份、海带粉2份、山楂粉4份、沙棘粉1.5份、黑枸杞粉1.2份、大豆粉4份、葡萄糖粉58份、黑芝麻粉4.5份、食盐0.25份。
本发明消除晚期肿瘤疼痛的食疗粉的制备方法,包括如下步骤:
1)按照组分的重量份比称取各组分;
2)将上述各组分按比例混合、粉粹、研磨成食疗粉末,食疗粉末的粒径为100目,即可得本发明消除晚期肿瘤疼痛的食疗粉。
实施例3,本发明消除晚期肿瘤疼痛的食疗粉,包括如下重量份的组分:小麦全粉22份、燕麦粉8份、海带粉4份、山楂粉5份、沙棘粉2.5份、黑枸杞粉1.8份、大豆粉5份、葡萄糖粉66份、黑芝麻粉5份、食盐0.3份。
本发明消除晚期肿瘤疼痛的食疗粉的制备方法,包括如下步骤:
1)按照组分的重量份比称取各组分;
2)将上述各组分按比例混合、粉粹、研磨成食疗粉末,食疗粉末的粒径为130目,即可得本发明消除晚期肿瘤疼痛的食疗粉。
典型病例:
病例1:王某,女,55岁,胰腺癌晚期,病人身体虚弱疼痛,服用本发明,服用消除晚期肿瘤疼痛的食疗粉20天后便感觉身体状况明显好转,全身乏力、消瘦、病灶部位疼痛等症状减轻,能够生活自理,目前还在服用过程中。
病例2:张某,男,60岁,胆管癌,西医医治无任何效果,半年后卧床不起,每夜疼痛难眠,服用本发明消除晚期肿瘤疼痛的食疗粉12天,下床行走,全身乏力、病灶部位疼痛等症状减轻,饭量恢复至常人量。
本发明以日常饮食作为食疗配方,保证身体营养需求的同时,对于肿瘤均有良好的预防和治疗效果,减轻了晚期肿瘤病人的痛苦,具有原料易得、花钱少、见效快、无痛苦等优点,使肿瘤患者摆脱了放化疗手术副作用大、机体易受损的痛楚,能有效提高肿瘤患者的生存质量,延长患者的自然寿命,具有良好的社会效益。
以上所述仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书内容所作的等效结构或等效流程变换,或直接或间接运用在其它相关的技术领域,均同理包括在本发明的专利保护范围内。
Claims (6)
1.一种消除晚期肿瘤疼痛的食疗粉,其特征在于,包括如下重量份的组分:小麦全粉15~25份、燕麦粉5~10份、海带粉1~5份、山楂粉3~5份、沙棘粉1~3份、黑枸杞粉1~2份、大豆粉3~5份、葡萄糖粉55~70份、黑芝麻粉4~6份、食盐0.2~0.5份。
2.根据权利要求1所述的一种消除晚期肿瘤疼痛的食疗粉,其特征在于,包括如下重量份的组分:小麦全粉16~24份、燕麦粉6~9份、海带粉2~4份、山楂粉4~5份、沙棘粉1.5~2.5份、黑枸杞粉1.2~1.8份、大豆粉4~5份、葡萄糖粉58~68份、黑芝麻粉4.5~5.5份、食盐0.25~0.35份。
3.根据权利要求1所述的一种消除晚期肿瘤疼痛的食疗粉,其特征在于,包括如下重量份的组分:小麦全粉20份、燕麦粉8份、海带粉3份、山楂粉4.5份、沙棘粉2份、黑枸杞粉1.5份、大豆粉4份、葡萄糖粉60份、黑芝麻粉5份、食盐0.3份。
4.根据权利要求1所述的一种消除晚期肿瘤疼痛的食疗粉,其特征在于,所述小麦全粉、燕麦粉、大豆粉、黑芝麻粉预先炒制后使用,所述山楂粉去核炒制后使用。
5.根据权利要求1所述的一种消除晚期肿瘤疼痛的食疗粉,其特征在于,所述消除晚期肿瘤疼痛的食疗粉在食用时每次食用50克,每天服用1~4次,温开水冲服。
6.一种消除晚期肿瘤疼痛的食疗粉的制备方法,其特征在于,包括如下步骤:
1)按照组分的重量份比称取各组分;
2)将上述各组分按比例混合、粉粹、研磨成食疗粉末,食疗粉末的粒径为100~150目,即可得本发明消除晚期肿瘤疼痛的食疗粉。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810164437.7A CN108378357A (zh) | 2018-02-28 | 2018-02-28 | 一种消除晚期肿瘤疼痛的食疗粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810164437.7A CN108378357A (zh) | 2018-02-28 | 2018-02-28 | 一种消除晚期肿瘤疼痛的食疗粉及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108378357A true CN108378357A (zh) | 2018-08-10 |
Family
ID=63069364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810164437.7A Pending CN108378357A (zh) | 2018-02-28 | 2018-02-28 | 一种消除晚期肿瘤疼痛的食疗粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108378357A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113261669A (zh) * | 2021-06-25 | 2021-08-17 | 赛杜恳医药生物科技(上海)有限公司 | 一种可用于抑制肿瘤发生的含有桦木酸的新型食品配方 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574500A (zh) * | 2009-06-17 | 2009-11-11 | 丛波 | 一种用于消除癌性疼痛的香驸马钱子粉 |
MX2013004930A (es) * | 2013-05-02 | 2014-11-24 | Direccion General De Educacion Superior Tecnologica De La Secretaria De Educacion Publica | Proceso para elaborar un suplemento alimenticio para prevenir tumores y controlar la presion arterial. |
CN105433383A (zh) * | 2015-11-09 | 2016-03-30 | 黄名玉 | 具有抗氧化、抗肿瘤功效的玫瑰茄保健营养粉 |
CN105533696A (zh) * | 2015-12-17 | 2016-05-04 | 北京振东光明药物研究院有限公司 | 一种粉剂型肿瘤全营养配方食品 |
-
2018
- 2018-02-28 CN CN201810164437.7A patent/CN108378357A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101574500A (zh) * | 2009-06-17 | 2009-11-11 | 丛波 | 一种用于消除癌性疼痛的香驸马钱子粉 |
MX2013004930A (es) * | 2013-05-02 | 2014-11-24 | Direccion General De Educacion Superior Tecnologica De La Secretaria De Educacion Publica | Proceso para elaborar un suplemento alimenticio para prevenir tumores y controlar la presion arterial. |
CN105433383A (zh) * | 2015-11-09 | 2016-03-30 | 黄名玉 | 具有抗氧化、抗肿瘤功效的玫瑰茄保健营养粉 |
CN105533696A (zh) * | 2015-12-17 | 2016-05-04 | 北京振东光明药物研究院有限公司 | 一种粉剂型肿瘤全营养配方食品 |
Non-Patent Citations (3)
Title |
---|
国家卫生计生委家庭司: "《中国家庭营养指南》", 31 December 2016, 中国人口出版社 * |
苗明三等: "《中药大辞典》", 30 June 2017, 山西科学技术出版社 * |
道仁: "《消食通络100种养生本草》", 31 January 2009, 吉林美术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113261669A (zh) * | 2021-06-25 | 2021-08-17 | 赛杜恳医药生物科技(上海)有限公司 | 一种可用于抑制肿瘤发生的含有桦木酸的新型食品配方 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103263012B (zh) | 一种药食同源的保健食品及其制备方法 | |
CN105596843A (zh) | 一种治疗脑血栓的药物组合物及其制备方法 | |
CN101011426B (zh) | 一种治疗癌症的药酒及其制备方法 | |
CN102846955A (zh) | 一种中药增高鞋垫 | |
CN102240310B (zh) | 一种降血糖组合物及其制备方法 | |
CN103977194A (zh) | 能有效治疗创面感染的外用药在制备治疗糖尿病足药物中的应用 | |
CN103919008A (zh) | 具有健脾补肾功能的保健粥及其制备方法 | |
CN108378357A (zh) | 一种消除晚期肿瘤疼痛的食疗粉及其制备方法 | |
CN106974278A (zh) | 一种***营养粉及其制备方法和应用 | |
CN110075258A (zh) | 一种糖尿病足溃疡外用药 | |
CN110227117A (zh) | 一种治疗骨质增生、腰腿疼痛的药物组合物及其制备方法 | |
CN104605372A (zh) | 一种基于恶性肿瘤放疗患者的营养药膳及制备方法 | |
KR20170059356A (ko) | 장위경련 치료용 고약 | |
CN103191378B (zh) | 一种用于治疗骨质增生的酒及制备方法 | |
CN102512569A (zh) | 一种治疗小儿厌食的中药口服汤剂 | |
CN103550410B (zh) | 一种减肥的药物组合物,含其制剂及其制备方法 | |
CN107737259A (zh) | 一种提高男性性功能的中药组方 | |
CN106727716A (zh) | 一种肿瘤康复汤及其制法 | |
CN102133286A (zh) | 一种治疗外伤的药膏及其制备方法 | |
CN101569660A (zh) | 一种用于舒筋活血、消炎止痛的外用中药及其制备方法 | |
CN105250650A (zh) | 一种治疗功能性呕吐的中药制剂 | |
CN104474203A (zh) | 治疗***增生和肥大的中药制剂 | |
CN103960398B (zh) | 一种含鱼眼草减肥茶及其制备方法 | |
CN108578621A (zh) | 一种治疗慢性腹泻的肚脐贴 | |
CN104758359B (zh) | 一种伪皮润肤膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180810 |